Pacira BioSciences, Inc. (PCRX)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 700,966 | 674,978 | 666,823 | 541,533 | 420,830 |
| Total assets | US$ in thousands | 1,553,520 | 1,574,390 | 1,681,200 | 2,075,350 | 1,274,510 |
| Total asset turnover | 0.45 | 0.43 | 0.40 | 0.26 | 0.33 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $700,966K ÷ $1,553,520K
= 0.45
Pacira BioSciences, Inc.'s total asset turnover has exhibited fluctuating trends over the years, as indicated by the data provided. The ratio has decreased from 0.33 in December 31, 2020, to 0.26 in December 31, 2021, reflecting a decrease in the efficiency of generating sales from total assets during that period. However, there has been an improvement in the total asset turnover from 0.26 in 2021 to 0.40 in 2022, indicating a more effective utilization of assets to generate revenue. This positive trend continued in the subsequent years, with ratios of 0.43 in 2023 and 0.45 in 2024, suggesting an increasing efficiency in generating sales from total assets. Overall, the company appears to have made significant progress in optimizing the utilization of its assets to drive revenue generation over the years.
Peer comparison
Dec 31, 2024